AMGN

Amgen Inc

438.12

+8.24+1.92%

Pre Market: 439.10 +0.98 +0.22%08:25 09/02 EDT

Daily

Weekly

Monthly

Quarterly

Yearly

OPEN/PREV CLOSE435.30/429.88

TODAY RANGE431.00-438.65

VOL737

MARKET CAP236.86B

52 WEEK RANGE262.49-447.03

AVG VOL (3M)2.70M

% TURNOVER0.43%

TURNOVER511.89M

P/E (TTM)27.21

% RANGE1.78%

EPS(TTM)16.10

P/E(FORWARD)27.71

P/B20.26

BVPS21.62

DIVIDEND10.08

P/S6.42

BETA--

DIV YIELD2.30%

FREE FLOAT MKT CAP236.30B

SHARES OUTSTANDING540.63M

NEXT EARNINGS11/02-11/06

FREE FLOAT539.34M

LOT SIZE1

EX-DATE08/21/2026

News

Press Releases

Financial Reports

Profile

Seeking Alpha·1h ago
Amgen slapped with U.K. suspension of rare-disorder therapy Tavneos
Barron‘s·15h ago
Heart-Drug Breakthroughs Can't Stop Biotech Stocks From Sliding
Barron‘s·17h ago
Investors Shrug Off Good News for Heart Patients From New Meds
NASDAQ·21h ago
Noteworthy ETF Inflows: SPTM, MRK, UNH, AMGN
Dow Jones·1d ago
Sino Biopharmaceutical Stock Sheds 2.2% in Hong Kong, Underperforms Competitors
Seeking Alpha·1d ago
Trump Admin To Target Biotechs With Curbs On Drug Pricing? What Investors Should Know
NASDAQ·1d ago
Aging Population Drives Healthcare Growth: Stocks to Watch
Seeking Alpha·1d ago
Big Pharma's Comeback Is Here: Winners, Losers, And 4 ETFs
TipRanks·1d ago
Entera is on the Cusp of the Trial That Could Unlock America’s Osteoporosis Drug Market (NASDAQ: ENTX)
Seeking Alpha·1d ago
4 stocks to watch on Monday: AMGN, LLY, ARM, and MSTR
NASDAQ·2d ago
Amgen's Repatha Cuts Death Risk 20% In High-Risk Patients Without Prior Heart Attack Or Stroke
TipRanks·2d ago
Amgen Repatha reduces risk of death in high-risk adults for first heart attack
Seeking Alpha·2d ago
Amgen's Repatha cuts death risk by 20% in heart study
PR Newswire·2d ago
AMGEN'S REPATHA® REDUCES RISK OF DEATH IN PATIENTS AT HIGH RISK FOR A FIRST HEART ATTACK OR STROKE
NASDAQ·3d ago
Amgen vs. Axsome Therapeutics: Which Healthcare Stock Is a Better Buy in 2026?

Same Industry

Name/Symbol

Change%

Price

AMGN

McKesson

MCK

-0.60%

888.07

Biogen Inc

BIIB

-1.35%

218.50

Bristol-Myers Squibb Company Celegne Contingent Value Rights

CELG-RT

+1.75%

0.1220

Shire

SHPG

0.00%

179.20

Celgene

CELG

0.00%

108.24

Lilly Eli & Co

LLY

+0.79%

Therapeuticsmd Inc

TXMD

-0.46%

2.170

Johnson & Johnson

JNJ

-0.82%

265.85

ABBV

Zoetis Inc

ZTS

+0.43%

77.43

GILD

Novo-Nordisk A/S

NVO

-1.41%

45.61

Bristol-Myers Squibb Co

BMY

-0.55%

66.58

ALXN

Pfizer

PFE

+1.11%

28.78

SNY

Sanofi FR

GCVRZ

0.00%

0.8711

Novartis

NVS

-0.54%

153.81

Dr Reddys Labs

RDY

+0.74%

12.22

GSK PLC

GSK

+0.74%

50.62

No content on the Webull website shall be considered a recommendation or solicitation for the purchase or sale of securities, options or other investment products. All information and data on the website is for reference only and no historical data shall be considered as the basis for judging future trends.